Impel Pharmaceuticals Inc

NASDAQ:IMPL 4:00:00 PM EDT

0.55

0.00 (+0.27%)

5:55:13 PM EDT: $0.59 +0.04 (+6.71%)

Market Cap (Intraday)	13.10M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8 Million
Adjusted EPS	-$0.36

See more estimates

10-Day MA	$0.56
50-Day MA	$0.89
200-Day MA	$1.79

See more pivots

Impel Pharmaceuticals Inc Stock, NASDAQ:IMPL

201 Elliott Avenue West, Suite 260, Seattle, Washington 98119

United States of America

Phone: +1.206.568.1466

Number of Employees: 160

http://impelpharma.com

Description

Impel Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of transformative therapies for patients suffering from diseases with high unmet medical needs with an initial focus on diseases of the central nervous system. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.